Home » Stocks » CFMS

Conformis, Inc. (CFMS)

Stock Price: $0.847 USD 0.018 (2.16%)
Updated Apr 16, 2021 4:00 PM EDT - Market closed
Pre-market: $0.870 +0.023 (2.73%) Apr 19, 4:30 AM
Market Cap 154.50M
Revenue (ttm) 68.76M
Net Income (ttm) -24.29M
Shares Out 182.43M
EPS (ttm) -0.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 16
Last Price $0.847
Previous Close $0.829
Change ($) 0.018
Change (%) 2.16%
Day's Open 0.820
Day's Range 0.810 - 0.860
Day's Volume 2,583,206
52-Week Range 0.602 - 1.490

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the market...

1 week ago - GlobeNewsWire

Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal® knee replacement implants enable expedited surgical time and reduc...

1 month ago - GlobeNewsWire

Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal® knee replacement implants enable expedited surgical time and reduc...

1 month ago - GlobeNewsWire

ConforMIS (CFMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 month ago - Zacks Investment Research

ConforMIS (CFMS) delivered earnings and revenue surprises of 27.27% and -0.08%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

BILLERICA, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the fourth quarter and year ended December 31, 2020.

1 month ago - GlobeNewsWire

Shares of ConforMIS (NASDAQ: CFMS) traded up as high as 37% in Tuesday's pre-market trading session. The company released a press release stating that the Therapeutic Goods Administration, part of the A...

1 month ago - Benzinga

On Wednesday, March 03, Conformis (NASDAQ:CFMS) will release its latest earnings report. Decipher the announcement with Benzinga's help.

1 month ago - Benzinga

CFMS stock is jumping as Conformis preps to introduce a knee replacement system in Australia. Here's what you should know.

1 month ago - InvestorPlace

The iTotal® PS total knee replacement system is designed so that its patient-specific implants fit the unique size and shape of each patient's knee, and provide optimal stability throughout the full ran...

1 month ago - GlobeNewsWire

BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an offering p...

2 months ago - GlobeNewsWire

BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis inten...

2 months ago - GlobeNewsWire

BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical device te...

2 months ago - GlobeNewsWire

Conformis (CFMS) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

3 months ago - Zacks Investment Research

BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief Execu...

3 months ago - GlobeNewsWire

Cordera™ Match Hip System combines the proven Cordera™ hip stem with Conformis' state-of-the-art, personalized pre-operative plans and patient-specific instruments. Cordera™ Match Hip System combines th...

4 months ago - GlobeNewsWire

BILLERICA, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will...

4 months ago - GlobeNewsWire

BILLERICA, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Bart Lagae as its new VP, International Sales & Marketing.

5 months ago - GlobeNewsWire

Conformis's (CFMS) CEO Mark Augusti on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

ConforMIS (CFMS) delivered earnings and revenue surprises of 25.00% and 0.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

BILLERICA, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September 30, 2020.

5 months ago - GlobeNewsWire

Conformis (NASDAQ: CFMS) releases its next round of earnings this Wednesday, November 04. Get the latest predictions in Benzinga's essential guide to the company's Q3 earnings report.

5 months ago - Benzinga

BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will...

5 months ago - GlobeNewsWire

ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Earnings Call to be Hosted on November 4, 2020 Earnings Call to be Hosted on November 4, 2020

6 months ago - GlobeNewsWire

Cordera™ Hip System with optional patient-specific instrumentation and personalized surgical plan joins the 3D Conformis Hip System as the latest hip technology from Conformis Cordera™ Hip System with o...

6 months ago - GlobeNewsWire

BILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to sell ...

6 months ago - GlobeNewsWire

BILLERICA, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) will participate in the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held September 21-23, 2...

7 months ago - GlobeNewsWire

BILLERICA, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) will participate in the upcoming 2020 H.C. Wainwright 22nd Annual Global Investment Conference, to be held virtually ...

7 months ago - GlobeNewsWire

BILLERICA, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and members of the Company’s executive mana...

7 months ago - GlobeNewsWire

BILLERICA, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it completed the second of three milestones pursuant to the License Agreement and Development Agr...

7 months ago - GlobeNewsWire

BILLERICA, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Farzin Khaghani as its new VP, US Marketing.

8 months ago - GlobeNewsWire

Clinical research published online in July 2020 in The Journal of Bone and Joint Surgery Reviews found that the patients studied, who all received Conformis patient-specific iTotal PS (posterior-stabili...

8 months ago - GlobeNewsWire

ConforMIS (CFMS) delivered earnings and revenue surprises of 76.92% and 32.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Conformis' (CFMS) CEO Mark Augusti on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

BILLERICA, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the second quarter ended June 30, 2020.

8 months ago - GlobeNewsWire

BILLERICA, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is bein...

8 months ago - GlobeNewsWire

ConforMIS (CFMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

Earnings Call to be Hosted on August 5, 2020

9 months ago - GlobeNewsWire

Conformis' (CFMS) latest iTotal Identity PS Knee System clears FDA hurdle, paving the way for providing better patient-specific pre-operative surgical plans.

9 months ago - Zacks Investment Research

iTotal® Identity PS joins iTotal® Identity CR as the latest personalized knee technology from Conformis iTotal® Identity PS joins iTotal® Identity CR as the latest personalized knee technology from Conf...

9 months ago - GlobeNewsWire

Conformis and Zimmer Biomet settled disputes related to Patient-Specific Instrument Patents for Use with Off-the-Shelf Knee, Hip, and Shoulder Implants Conformis and Zimmer Biomet settled disputes relat...

10 months ago - GlobeNewsWire

Dr. Malte Asseln awarded annual prize by German Society for Biomedical Engineering at the VDE Association and the Klee Family Foundation for his scientific computer-and-image-based workflow to optimize ...

10 months ago - GlobeNewsWire

Conformis (CFMS) CEO Mark Augusti on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

ConforMIS (CFMS) delivered earnings and revenue surprises of -55.56% and -13.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

11 months ago - Zacks Investment Research

BILLERICA, Mass., April 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced that on April 17, 2020 the Company entered into a $4,719,800 promissory note with East West Bank (NAS...

11 months ago - GlobeNewsWire

Withdraws Previous 2020 Growth Outlook

1 year ago - GlobeNewsWire

Inside the top-ranked stocks that have been exhibiting rising P/E ratios.

Other stocks mentioned: KL, LONE, NOVN, UEC
1 year ago - Zacks Investment Research

Conformis, Inc. (CFMS) CEO Mark Augusti on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

About CFMS

Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee; and iTotal Identity, a knee system. It also provides Conformis Hip System and Cordera h... [Read more...]

Industry
Medical Devices
IPO Date
Jul 1, 2015
Stock Exchange
NASDAQ
Ticker Symbol
CFMS
Full Company Profile

Financial Performance

In 2020, Conformis's revenue was $68.76 million, a decrease of -11.19% compared to the previous year's $77.43 million. Losses were -$24.29 million, -14.70% less than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Conformis stock is "Buy." The 12-month stock price forecast is 2.33, which is an increase of 175.12% from the latest price.

Price Target
$2.33
(175.12% upside)
Analyst Consensus: Buy